bexotegrast , CAS No.2376257-44-0, Antagonist of integrin; alpha V subunit

Item Number
B608031
Grouped product items
SKUSizeAvailabilityPrice Qty
B608031-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$615.90
B608031-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,844.90

Basic Description

SynonymsHY-137561 | 2376257-44-0 | (S)-4-[(2-Methoxyethyl)[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-[(quinazolin-4-yl)amino]butanoic acid | BDBM50594476 | CS-0140405 | GLXC-26826 | Bexotegrast | PLN74809 | PLN-74809 | Butanoic acid, 4-[(2-methox
Specifications & PurityMoligand™
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of integrin; alpha V subunit

Associated Targets(Human)

ITGAV Tchem Integrin alpha-V (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name (2S)-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(quinazolin-4-ylamino)butanoic acid
INCHI InChI=1S/C27H36N6O3/c1-36-18-17-33(15-5-4-8-21-12-11-20-7-6-14-28-25(20)31-21)16-13-24(27(34)35)32-26-22-9-2-3-10-23(22)29-19-30-26/h2-3,9-12,19,24H,4-8,13-18H2,1H3,(H,28,31)(H,34,35)(H,29,30,32)/t24-/m0/s1
InChi Key CWOFQJBATWQSHL-DEOSSOPVSA-N
Canonical SMILES COCCN(CCCCc1nc2c(CCCN2)cc1)CC[C@@H](C(=O)O)Nc1ncnc2ccccc12
Isomeric SMILES COCCN(CCCCC1=NC2=C(CCCN2)C=C1)CC[C@@H](C(=O)O)NC3=NC=NC4=CC=CC=C43
PubChem CID 135390719

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Fabregat I, Moreno-Càceres J, Sánchez A, Dooley S, Dewidar B, Giannelli G, Ten Dijke P, IT-LIVER Consortium.  (2016)  TGF-β signalling and liver disease..  FEBS J,  283  (12): (2219-32).  [PMID:26807763] [10.1021/op500134e]
2. Saito A, Horie M, Nagase T.  (2018)  TGF-β Signaling in Lung Health and Disease..  Int J Mol Sci,  19  (8): (2460).  [PMID:30127261] [10.1021/op500134e]
3. Decaris ML, Schaub JR, Chen C, Cha J, Lee GG, Rexhepaj M, Ho SS, Rao V, Marlow MM, Kotak P et al..  (2021)  Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPF..  Respir Res,  22  (1): (265).  [PMID:34666752] [10.1021/op500134e]

Solution Calculators